血栓切除器材市场规模、份额和成长分析（按技术、类型、用途、应用和地区划分）—产业预测（2026-2033 年）

预计到 2024 年，全球血栓切除器材市场规模将达到 20.1 亿美元，到 2025 年将达到 21.3 亿美元，到 2033 年将达到 34.5 亿美元，预测期（2026-2033 年）的复合年增长率为 6.2%。

血栓切除器械市场正经历强劲成长，其驱动因素包括心血管疾病盛行率的上升、技术进步以及人口老化。微创器械和血栓摘取支架等领域的创新显着改善了患者的治疗效果，简化了手术流程，减少了併发症，并加快了康復速度。随着製造商将研发投入优先，以开发有效的解决方案，这种快速的创新成长至关重要。此外，老年人罹患心血管疾病和血栓症的风险更高，这进一步推动了对血栓切除器械的需求。随着老年人口的增长，对高效及时的治疗方案的需求变得日益迫切，这使得血栓切除器械成为现代医疗保健策略的重要组成部分。

血栓切除器械市场驱动因素

心血管疾病（如中风和心臟病）发病率的不断上升显着推动了血栓切除装置的需求。随着人口老化和久坐生活方式的日益普遍，这些健康问题的盛行率持续上升。血栓切除装置对于快速清除血栓、恢復正常血流至关重要，在改善患者预后方面发挥关键作用。这些装置在紧急情况下的有效性凸显了其在医疗保健领域的重要性，也促使医疗机构寻求更先进的解决方案来应对心血管急症，进一步激发了人们对血栓切除装置市场的兴趣和投资。

限制血栓切除器械市场的因素

与其他医疗干预措施一样，血栓切除器械市场也面临血栓切除手术固有风险带来的重大限制。潜在的併发症，例如血管损伤、出血、感染以及血栓脱落和栓塞的风险，引发了人们对安全性和有效性的担忧。这些担忧影响着医疗服务提供者和病患的选择，最终影响血栓切除器械的接受度和广泛应用。只要对潜在不良后果的担忧持续存在，相关人员就会对这些医疗设备保持谨慎态度，这可能会阻碍市场的整体成长和发展。

血栓切除器械市场趋势

由于缺血性中风发病率不断上升，血栓切除器械市场正经历显着增长，推动了对先进医疗干预措施需求的激增。主要产业参与者正集中研发资源，致力于创新和改进产品，专注于开发抽吸装置、血栓切除装置和抽吸导管等先进技术，以有效治疗缺血性中风。这些新一代器械具有更强大的追踪功能、更有效率的血栓清除过程和更人性化的设计，有助于医疗专业人员提高手术效率。这种对技术创新的重视有望改善患者预后，并重塑治疗模式。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球血栓切除器材市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 机械血栓切除术
• 抽吸血栓切除手术
• 血栓溶解切除术

全球血栓切除器材市场规模（按类型和复合年增长率划分）（2026-2033 年）

• 自动装置
• 手动装置

全球血栓切除器材市场规模（按用途和复合年增长率划分）（2026-2033 年）

• 可重复使用的
• 一次性的

全球血栓切除器材市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 週边血管疾病
• 冠状动脉疾病
• 神经系统疾病

全球血栓切除器材市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Medtronic（Ireland）
• Abbott（United States）
• Boston Scientific（United States）
• Stryker（United States）
• Johnson & Johnson（United States）
• Penumbra（United States）
• Terumo（Japan）
• Koninklijke Philips（Netherlands）
• Becton, Dickinson and Company（BD）（United States）
• Merit Medical Systems（United States）
• Teleflex Incorporated（United States）
• AngioDynamics（United States）
• Edwards Lifesciences（United States）
• Cerenovus（United States）
• Vascular Solutions（United States）
• Balt Extrusion（United States）
• Acandis（Germany）

结论与建议

Thrombectomy Devices Market size was valued at USD 2.01 Billion in 2024 and is poised to grow from USD 2.13 Billion in 2025 to USD 3.45 Billion by 2033, growing at a CAGR of 6.2% during the forecast period (2026-2033).

The thrombectomy devices market is experiencing robust growth, driven by a combination of increasing cardiovascular disease prevalence, technological advancements, and an expanding aging population. Innovations in the field, such as minimally invasive devices and stent retriever technologies, have significantly enhanced patient outcomes and streamlined procedures, leading to reduced complications and faster recovery times. This surge in technology is pivotal as manufacturers prioritize research and development to create effective solutions. Additionally, the aging demographic is particularly vulnerable to cardiovascular issues and blood clots, escalating the demand for thrombectomy devices. As this population grows, the need for efficient and timely treatment solutions becomes increasingly crucial, positioning thrombectomy devices as an essential component of modern healthcare strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Thrombectomy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Thrombectomy Devices Market Segments Analysis

Global Thrombectomy Devices Market is segmented by Technology, Type, Utility, Application and region. Based on Technology, the market is segmented into Mechanical Thrombectomy, Aspiration Thrombectomy and Rheolytic Thrombectomy. Based on Type, the market is segmented into Automated Devices and Manual Devices. Based on Utility, the market is segmented into Reusable Devices and Disposable Devices. Based on Application, the market is segmented into Peripheral Diseases, Coronary Disease and Neural Diseases. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Thrombectomy Devices Market

The rising incidence of cardiovascular diseases such as strokes and heart attacks significantly propels the demand for thrombectomy devices. With an increasingly aging population and a rise in sedentary lifestyles, the prevalence of these health conditions continues to trend upward. Thrombectomy devices are essential in swiftly removing blood clots and restoring normal blood flow, which plays a crucial role in improving patient outcomes. The effectiveness of these devices in critical situations highlights their importance in medical settings, driving further interest and investment in the thrombectomy devices market as healthcare providers seek advanced solutions for managing cardiovascular emergencies.

Restraints in the Thrombectomy Devices Market

The thrombectomy devices market faces significant restraints due to the inherent risks associated with thrombectomy procedures, much like other medical interventions. Potential complications, including vessel injury, bleeding, infection, or the risk of the clot being dislodged and causing an embolism, contribute to concerns regarding safety and efficacy. These apprehensions can affect the choices made by healthcare providers and patients, ultimately influencing the acceptance and adoption of thrombectomy devices. As concerns about potential adverse outcomes persist, they may hinder the overall growth and advancement of the market, as stakeholders remain cautious in their approach to these medical devices.

Market Trends of the Thrombectomy Devices Market

The thrombectomy devices market is experiencing significant growth driven by the rising incidence of ischemic strokes, prompting a surge in demand for advanced medical interventions. Major industry players are increasingly channeling resources into research and development to innovate and enhance product offerings, particularly focusing on sophisticated technologies such as suction devices, clot retrievers, and aspiration catheters tailored for effective ischemic stroke management. These next-generation devices are engineered with enhanced tracking capabilities, streamlined clot retrieval processes, and user-friendly designs, which facilitate improved procedural efficiency for healthcare professionals. As a result, this focus on technological advancement is poised to uplift patient outcomes and reshape treatment paradigms.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Thrombectomy Devices Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Mechanical Thrombectomy
• Aspiration Thrombectomy
• Rheolytic Thrombectomy

Global Thrombectomy Devices Market Size by Type & CAGR (2026-2033)

• Market Overview
• Automated Devices
• Manual Devices

Global Thrombectomy Devices Market Size by Utility & CAGR (2026-2033)

• Market Overview
• Reusable Devices
• Disposable Devices

Global Thrombectomy Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Peripheral Diseases
• Coronary Disease
• Neural Diseases

Global Thrombectomy Devices Market Size & CAGR (2026-2033)

• North America (Technology, Type, Utility, Application)
  • US
  • Canada
• Europe (Technology, Type, Utility, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Type, Utility, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Type, Utility, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Type, Utility, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerenovus (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascular Solutions (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balt Extrusion (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acandis (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations